Milestone Pharmaceuticals Inc. - MIST
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 26, 2026 | SCHEDULE 13G/A | Trails Edge Capital Partners, LP | 4.3% | 5,333,333 | View |
| Mar 26, 2026 | SCHEDULE 13G/A | Trails Edge Biotechnology Master Fund, LP | 4.3% | 5,333,333 | View |
| Mar 26, 2026 | SCHEDULE 13G/A | Ortav Yehudai | 4.3% | 5,333,333 | View |
| Dec 23, 2025 | SCHEDULE 13G | Propel Bio Management, LLC | 9.9% | 8,861,186 | View |
| Dec 23, 2025 | SCHEDULE 13G | Leen Kawas | 9.9% | 8,861,186 | View |
| Dec 23, 2025 | SCHEDULE 13G | Richard Kayne | 9.9% | 8,861,186 | View |
| Dec 23, 2025 | SCHEDULE 13G | Propel Bio Partners LLC | 9.9% | 8,861,186 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Trails Edge Capital Partners, LP | 9.9% | 9,017,880 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Trails Edge Biotechnology Master Fund, LP | 9.9% | 9,017,880 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Ortav Yehudai | 9.9% | 9,017,880 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | RTW Investments, LP | 9.9% | 9,155,168 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Roderick Wong | 9.9% | 9,155,168 | View |
| Nov 13, 2025 | SCHEDULE 13G | Adage Capital Management, L.P. | 9.99% | 8,659,064 | View |
| Nov 13, 2025 | SCHEDULE 13G | Robert Atchinson | 9.99% | 8,659,064 | View |
| Nov 13, 2025 | SCHEDULE 13G | Phillip Gross | 9.99% | 8,659,064 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.